You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our RPS6KA3 (RPS6KA3) ELISA Kits

Full name:
Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 ELISA Kits (RPS6KA3)
On are 0 Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) ELISA Kits from different suppliers available. Additionally we are shipping RPS6KA3 Antibodies (139) and RPS6KA3 Proteins (12) and many more products for this protein. A total of 160 RPS6KA3 products are currently listed.
CLS, HU-3, ISPK-1, MAPKAPK1B, MPK-9, MRX19, p90-RSK2, pp90RSK2, RSK, RSK2, S6K-alpha3
list all ELISA KIts Gene Name GeneID UniProt
Mouse RPS6KA3 RPS6KA3 110651 P18654
Human RPS6KA3 RPS6KA3 6197 P51812

Show all synonyms

More ELISA Kits for RPS6KA3 Interaction Partners

Mouse (Murine) Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) interaction partners

  1. Downregulation of Rps6ka3 is a promising strategy for the treatment of multiple sclerosis.

  2. Data show that the phosphoinositide-dependent kinase 1 (PDK1 (show PDPK1 ELISA Kits))-p90 (show GPAM ELISA Kits) kDa ribosomal S6 kinases (Rsks) Rsk1 (show RPS6KA1 ELISA Kits)/2 pathway is critical for establishment and maintenance of a normal Langerhans cells (LC) network.

  3. RSK2 regulates craniofacial development including tooth development and patterning via novel transcriptional targets

  4. The results of this study show that RSK2 loss-of-function is associated in the dentate gyrus with multi-level alterations that encompass modifications of glutamate (show GRIN1 ELISA Kits) receptor channel properties, synaptic transmission.

  5. We propose that loss of function mutations in RSK2 that lead to Coffin-Lowry syndrome are related to defects in neuronal growth due to impaired RSK2-dependent PLD1 activity resulting in a reduced vesicle fusion rate and membrane supply.

  6. RSK2 interacted and phosphorylated GSK-3beta at Ser9. Notably, GSK-3beta phosphorylation at Ser9 was suppressed in RSK2(-/-) mouse embryonic fibroblasts.

  7. Pin1 (show PIN1 ELISA Kits) plays a critical role in tumorigenesis plausibly via physical interaction with RSK2 and reciprocal phosphorylation

  8. This study showed that RSK2 signaling contributes to morphine analgesia in the tail withdrawal response.

  9. Results show increased protein levels of Rsk1 (show RPS6KA1 ELISA Kits) and Rsk2 in the striatum of Huntington disease (show HTT ELISA Kits) mice and and striatal cells transfected with full-length mutant Huntingtin (show HTT ELISA Kits).

  10. The study demonistrated that revealed a novel role for RSK2 in cognitive processes and uncovers the critical implication of an intriguing brain structure in place aversion learning.

Human Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) interaction partners

  1. Results indicate that the phosphorylation of EphA2 (show EPHA2 ELISA Kits) at Ser (show SIGLEC1 ELISA Kits)-897 is controlled by RSK (show RPS6KA1 ELISA Kits) and the RSK (show RPS6KA1 ELISA Kits)-EphA2 (show EPHA2 ELISA Kits) axis might contribute to cell motility and promote tumour malignant progression.

  2. miR (show MLXIP ELISA Kits)-191 represses proliferation in primary human fibroblasts via targeting multiple proto-oncogenes, including CDK9 (show CDK9 ELISA Kits), NOTCH2 (show NOTCH2 ELISA Kits), and RPS6KA3.

  3. This is the first report of exon skipping from an exonic mutation of RPS6KA3, demonstrating that a missense mutation and concomitant disruption of normal splicing contribute to the manifestation of CLS (show CLS ELISA Kits)

  4. SL0101 and BI-D1870 induce distinct off-target effects in mTORC1-p70S6K (show RPS6KB1 ELISA Kits) signaling, and thus, the functions previously ascribed to RSK1 (show RPS6KA1 ELISA Kits)/2 based on these inhibitors should be reassessed.

  5. Rsk2-mediated inhibition of hyperplasia has now been demonstrated to occur in the arthritic synovium.

  6. Study identifies RSK2 as a new kinase that regulates NHE3 (show SLC9A3 ELISA Kits) activity by direct phosphorylation.

  7. RPS6KA3 in three unrelated Coffin-Lowry syndrome patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations, were analyzed.

  8. Activated RSK2 directly interacts with and phosphorylates FGFR1 (show FGFR1 ELISA Kits), thereby modulating receptor signaling through regulation of endocytosis.

  9. 14-3-3 (show YWHAQ ELISA Kits) binding promotes PDCD4 (show PDCD4 ELISA Kits) degradation, suggesting an important role for RSK (show RPS6KA1 ELISA Kits) in the inactivation of PDCD4 (show PDCD4 ELISA Kits) in melanoma.

  10. Kaposi's sarcoma-associated herpesvirus ORF45 mediates activation of the HIV-1 long terminal repeat via RSK2.

RPS6KA3 Antigen Profile

Antigen Summary

This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).

Alternative names and synonyms associated with RPS6KA3

  • ribosomal protein S6 kinase polypeptide 3 (Rps6ka3) Elisa Kit
  • ribosomal protein S6 kinase, 90kDa, polypeptide 3 (RPS6KA3) Elisa Kit
  • CLS Elisa Kit
  • HU-3 Elisa Kit
  • ISPK-1 Elisa Kit
  • MAPKAPK1B Elisa Kit
  • MPK-9 Elisa Kit
  • MRX19 Elisa Kit
  • p90-RSK2 Elisa Kit
  • pp90RSK2 Elisa Kit
  • RSK Elisa Kit
  • RSK2 Elisa Kit
  • S6K-alpha3 Elisa Kit

Protein level used designations for RPS6KA3

90 kDa ribosomal protein S6 kinase 3 , MAP kinase-activated protein kinase 1b , MAPK-activated protein kinase 1b , MAPKAP kinase 1b , MAPKAPK-1b , RSK-2 , S6K-alpha-3 , p90-RSK 3 , p90RSK3 , ribosomal S6 kinase 2 , ribosomal protein S6 kinase 2 , ribosomal protein S6 kinase alpha-3 , insulin-stimulated protein kinase 1

110651 Mus musculus
6197 Homo sapiens
Did you look for something else?